You are here: Industry Insights > FTC

News List

FTC’s Antitrust Intensifies, Where Does Pharmaceutical Innovation Go? PharmaSources/Xiaobing
August 23, 2023
In fact, the FTC has more than once blocked MNC’s mergers and acquisitions under the name of “antitrust”. So, what impact will this have on the US pharmaceutical ecosystem? What challenges does it pose to domestic innovative drugs going global?
President Biden’s Executive Order to Support Biosimilar Drugs Will Provide Lower Cost Options for Patients firstwordpharma
July 12, 2021
The Biosimilars Forum applauds President Biden's directions to the U.S. Department of Health and Human Services "to increase support for generic and biosimilar drugs, which provide low-cost options for patients" .
FDA & FTC Warn Five Companies Illegally Selling Dietary Supplements Claiming to Treat Infertility americanpharmaceuticalreview
June 02, 2021
The U.S. FDA and the Federal Trade Commission issued warning letters to five companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent infertility and other reproductive health disorders in violation of the ...
Competition and Markets Authority investigating AstraZeneca’s Alexion acquisition europeanpharmaceuticalreview
May 31, 2021
The UK’s competition authority will assess whether AstraZeneca’s acquisition of Alexion will result in a “substantial lessening of competition”.
International trade officials to review impact of pharma mergers europeanpharmaceuticalreview
March 19, 2021
The Federal Trade Commission will work with international regulators to review the effects of pharma mergers and update approaches to analysing them.
Federal Trade Commission forms multilateral working group on pharma mergers pharmaceutical-technology
March 18, 2021
The US Federal Trade Commission (FTC) has launched a multilateral working group with domestic and international partners to reassess their approach to analysing the impacts of mergers and acquisitions (M&A) in the pharmaceutical industry.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.
FTC Clears AbbVie’s Acquisition of Allergan contractpharma
May 07, 2020
Only one Allergan director will join the AbbVie board after close.
FDA and FTC issue warning letters to companies selling fraudulent COVID-19 products europeanpharmaceuticalreview
March 11, 2020
The US agencies have issued letters to seven companies, and removed online listings from others, whose products falsely claim to prevent or treat coronavirus.
Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19 PRNewswire
March 10, 2020
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant risks to patient health and vi

Previous page 1 2 Next page